Filing Details

Accession Number:
0001209191-12-042119
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-08-16 14:31:00
Reporting Period:
2012-08-15
Filing Date:
2012-08-16
Accepted Time:
2012-08-16 14:31:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
949858 Oncogenex Pharmaceuticals Inc. OGXI In Vitro & In Vivo Diagnostic Substances (2835) 954343413
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1230729 Jack Goldstein 1522 217Th Place Se
Suite 100
Bothell WA 98021
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-08-15 1,000 $14.38 1,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct